The risk of developing more than one skin melanoma over a ten-year period has seen a ten-fold increase in Sweden since the 1960s, a new study by researchers at Karolinska Institutet and Lund University published in the Journal of the National Cancer Institute reports.
Archive | Melanoma News
Neoadjuvant Nivolumab/Ipilimumab Improves RFS in Stage III Macroscopic Melanoma
The neoadjuvant combination of nivolumab (Opdivo) and ipilimumab (Yervoy) continued to demonstrate a benefit in relapse-free survival (RFS) compared with the combination given in the adjuvant setting in patients with stage III macroscopic melanoma, according to 3-year follow-up results of the phase 1b OpACIN trial.1
Posted in Melanoma News, Health Professionals, Of Interest
The predictive and prognostic significance of cell-free DNA concentration in melanoma
In this study with a discovery cohort (n = 20) and expansion cohort (n = 166) including metastatic melanoma patients and healthy donors (n = 116), researchers sought to validate universal predictive and prognostic biomarkers, given that most of the liquid?biopsy biomarkers depend on the analyses of oncogenic mutations, however, approximately 20% of melanoma patients […]
Posted in Melanoma News, Publications, Scientific Publications
Real-world outcomes of advanced melanoma patients not represented in phase 3 trials
Researchers sought to report on systemically treated patients with advanced melanoma, that were not represented in phase 3 trials, to support clinical decision?making.
Posted in Melanoma News, Publications, Scientific Publications
